Bausch Health Provides Update Following Oral Order in XIFAXAN® Patent Litigation
— Organization to Attraction Anticipated Court docket Choice on Particular XIFAXAN® Patents – LAVAL, Quebec, July 28, 2022 /PRNewswire/ — Bausch Health Providers Inc. (NYSE/TSX: BHC), and its gastroenterology company…






